06 April 2016
: Case report
Clostridium Perfringens Infection in a Febrile Patient with Severe Hemolytic Anemia
Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Masamitsu HashibaBCDE, Atsutoshi TominoBCD, Nobuyoshi TakenakaBCD, Tomonori HattoriBCD, Hideki KanoBCD, Masanobu TsudaBCD, Naoshi TakeyamaABCDEFDOI: 10.12659/AJCR.895721
Am J Case Rep 2016; 17:219-223
Abstract
BACKGROUND: Clostridium perfringens (C. perfringens) can cause various infections, including gas gangrene, crepitant cellulitis, and fasciitis. While C. perfringens sepsis is uncommon, it is often rapidly fatal because the alpha toxin of this bacterium induces massive intravascular hemolysis by disrupting red blood cell membranes.
CASE REPORT: We present the case of a male patient with diabetes who developed a fatal liver abscess with massive intravascular hemolysis and septic shock caused by toxigenic C. perfringens. The peripheral blood smear showed loss of central pallor, with numerous spherocytes. Multiplex PCR only detected expression of the cpa gene, indicating that the pathogen was C. perfringens type A.
CONCLUSIONS: C. perfringens infection should be considered in a febrile patient who has severe hemolytic anemia with a very low MCV, hemolyzed blood sample, and negative Coombs test. The characteristic peripheral blood smear findings may facilitate rapid diagnosis.
Keywords: Anemia, Hemolytic - microbiology, Aged, 80 and over, Clostridium Infections - diagnosis, Clostridium perfringens, Fatal Outcome, Fever - microbiology, Liver Abscess - microbiology, Shock, Septic - microbiology
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947628
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947148
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946611
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948042
Most Viewed Current Articles
21 Jun 2024 : Case report
97,828
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,727
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
32,839
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,613
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030